Peptris Technologies

Peptris Technologies is a biotechnology startup with a slogan "AI plays tetris with proteins". Founded in 2019 and headquartered in India, Peptris is utilizing AI for preclinical drug discovery in the fields of oncology, inflammation, and rare diseases. The company has developed a range of AI models to forecast crucial parameters for identifying potential drug candidates. These models are managed by an automated pipeline that streamlines large purchasable compound datasets to pinpoint potential hits and generate novel compound variations. This process minimizes the number of compounds requiring wet lab testing, leading to efficient, rapid, and cost-effective drug discovery. The startup recently secured a $1.00M Pre Seed Round investment on 19 December 2023 from Speciale Invest, demonstrating investors' confidence in Peptris' innovative approach to drug discovery. With promising wet lab results from its proprietary discovery programs, Peptris is actively transitioning these findings into preclinical development. The company's focus on leveraging AI and automation to enhance drug discovery efficiency sets it apart in the biotechnology landscape, making it an exciting prospect for potential investors seeking innovative solutions in the field.